CClinicalTrials.gg
WithdrawnNCT05156463Updated Apr 28, 2022

The PAI Trial for Breast and Colon Cancer Survivors

An interventional study of PAI Tool and Exercise Coaching in Breast Cancer and Colon Cancer, sponsored by Milton S. Hershey Medical Center. Withdrawn. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-28.

Sponsored by Milton S. Hershey Medical Center · Not applicable, Interventional, and Supportive care

Why this study was withdrawn
Award not yet received and PI is transferring to a different institution
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The purpose of the study is to determine if a Physical Activity Index (PAI) tool that collects measures on physical activity, strength training and sedentary behavior can be used in a clinical setting to monitor patient behavior and provide specific recommendations on how to achieve and maintain behavior goals. The tool will be used after treatment is completed in breast and colon cancer survivors and will test if physician counseling combined with patient self-monitoring improves physical activity and reduces sedentary behavior over time.

02

Conditions studied

  • Breast Cancer
  • Colon Cancer

Browse trials for

Keywords

  • Adult Cancer Survivors
  • Geriatrics
  • Gerontology
03

In context

Colonic Neoplasms

1,433 studies on the registry are indexed under Colonic Neoplasms; 358 are open to participants now.

Browse Colonic Neoplasms studies →

Lead sponsor

Milton S. Hershey Medical Center is the lead sponsor of 480 studies on the registry; 61 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 42 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Women ages 60 years or older diagnosed with breast cancer and women or men ages 60 years or older diagnosed with colon cancer within the last 5 years
  • ≥ 3 months post-completion of last prescribed treatment (i.e., Chemotherapy, radiation therapy or surgery)
  • Stages I-III (no stage 0 or metastatic cases will be included)
  • Able to understand spoken and written instructions in English
  • Participate in 60 minutes or more of MVPA (moderate to vigorous-intensity physical activity)/week for previous 6 months
  • Have internet access or access to data sharing plan
  • Willing to come to four Penn State Health visits over the course of a year, completing requested questionnaires
  • Willing to use Garmin Vivofit device, participate in exercise coaching sessions and complete exercise logs between visits

Exclusion criteria

Exclusion Criteria:

  • Prior respiratory, joint or cardiovascular problems precluding PA
  • Metastatic disease
  • Planned elective surgery during intervention/follow-up
  • Exhibit gross cognitive impairment

We will not include any of the following vulnerable populations: adults unable to consent, individuals who are not yet adults, pregnant women, neonates, or prisoners.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • No intervention
    Control

    Participants will receive standard follow-up survivorship care, an accelerometer to measure physical activity and NCCN (National Comprehensive Cancer Network) patient materials.

  • Experimental
    Treatment

    Participants will receive same materials as standard of care group. In addition participants will use PAI Activity tool, Garmin activity tracker and exercise logs, and also receive periodic exercise coaching.

    Combination Product: PAI Tool and Exercise Coaching

Interventions

  • Combination productPAI Tool and Exercise Coaching

    Use of PAI tool and self-monitoring tools to increase physical activity and reduce sedentary behaviors. Participants will receive a personalized physical assessment and counseling from healthcare provider, exercise logs and a Garmin activity tracker to use between visits and 9 exercise coaching calls between clinical visits.

06

What researchers measure

Primary outcomes

  1. Introduce PAI tool to increase PA and reduce sedentary behavior

    PAI Tool: frequency and time spent in strenuous moderate and mild PA over 7 days and self reported television time or sedentary screen time per week

    Time frame: 7 days prior to each visit clinical visit (Baseline, 3 months, 6 months, 12 months)

  2. Change in activity as measured by Community Healthy Activities Model Program for Seniors (CHAMPS) Questionnaire for Older Adults

    This self-report questionnaire assesses weekly frequency and duration of a variety of lifestyle physical activities that are meaningful and appropriate for older adults. Scores are recorded based on number of repetitions the activity was completed and the hours spent doing the activity from less than 1 hour to 9 or more hours.

    Time frame: Baseline, 3 months, 6 months,12 months

  3. Use of Actigraph to measure changes in activity and sedentary behavior

    Activity patterns and sedentary behavior based on 7 days of wear before clinical visit

    Time frame: 7 days prior to each clinical visit (Baseline, 3 months, 6 months, 12 months)

Secondary outcomes

  1. Modified Cancer and Aging Research Group (CARG) plus National Health and Nutrition Examination Survey (NHANES) and Patient-Reported Outcomes Measurement Information System (PROMIS) Geriatric Assessment Study Patient Questionnaire

    Aggregated assessment of self-reported information about demographic data, daily activities, nutritional status, medication use and health behaviors.

    Time frame: Baseline, 3 months, 6 months,12 months

  2. Exercise Self-Efficacy Scale This scale assesses an individual's beliefs in their ability to continue exercising on a 3 time/week basis at moderate intensities for 40+ min. per session in the future.

    For 8 items, participants indicate their confidence to execute the behavior on a 100-pt percentage scale comprised of 10-pt increments, ranging from 0% (not at all confident) to 100% (highly confident).

    Time frame: Baseline, 3 months, 6 months, 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05156463
Lead sponsor
Milton S. Hershey Medical Center
Collaborators
National Institutes of Health (NIH)
Responsible party
Shirley Bluethmann (Assistant Professor, Milton S. Hershey Medical Center) — Principal investigator
First posted
Dec 14, 2021
Start date
Apr 12, 2022
Primary completion
Apr 12, 2022
Completion
Apr 12, 2022
Last update
Apr 28, 2022

Study contacts

Shirley M Bluethmann, PhD
principal investigator · Milton S. Hershey Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion